LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY

Bibliographic Details
Main Authors:	Jacob, A, Palace, J, Waters, P, Jarius, S, Littleton, E, Malik, M, Nicholas, R, Solomon, T, Silber, E, Constantinescu, C, Vincent, A, Boggild, M
Format:	Conference item
Published:	2009

Similar Items

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

NMO-IgG in the diagnosis of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2007)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
by: Jarius, S, et al.
Published: (2007)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
by: Akman-Demir, G, et al.
Published: (2008)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
by: Jarius, S, et al.
Published: (2007)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
by: Downer, J, et al.
Published: (2012)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
by: Jarius, S, et al.
Published: (2008)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
by: Sudulagunta, Sreenivasa Rao, et al.
Published: (2015-11-01)

NMO-DBr: the Brazilian Neuromyelitis Optica Database System
by: Marco A. Lana-Peixoto, et al.
Published: (2011-08-01)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
by: Waters, P, et al.
Published: (2008)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
by: Waters, P, et al.
Published: (2007)

Neuromyelitis Optica (NMO) in Children: A Rare Case Report
by: Dodik Tugasworo, et al.
Published: (2020-12-01)

Detection and clinical value of NMO-IgG in neuromyelitis optica
by: De-hui HUANG, et al.
Published: (2014-09-01)

Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01)

Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis
by: Jarius, S, et al.
Published: (2007)

Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks
by: Murchison, A, et al.
Published: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
by: Min, J, et al.
Published: (2010)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
by: Paul, F, et al.
Published: (2007)

DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK
by: Kitley, J, et al.
Published: (2012)

Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
by: Min, J, et al.
Published: (2012)

Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
by: Mohammad Hossein Harirchian, et al.
Published: (2015-02-01)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
by: Friedemann Paul, et al.
Published: (2007-04-01)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
by: Tarso Adoni, et al.
Published: (2008-06-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
by: Viegas, S, et al.
Published: (2009)

A practical guide to the treatment of neuromyelitis optica.
by: Palace, J, et al.
Published: (2012)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
by: Jarius, S, et al.
Published: (2008)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
by: Jarius, S, et al.
Published: (2007)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
by: Luppe, S, et al.
Published: (2014)

The evolving clinical spectrum of neuromyelitis optica
by: Viegas, S, et al.
Published: (2008)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
by: Akman-Demir, G, et al.
Published: (2011)

Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
by: Absoud, M, et al.
Published: (2014)